Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moolec Science SA (MLEC) vs VivoSim Labs, Inc. (VIVS)

Moolec Science SA and VivoSim Labs, Inc. are both Biotechnology companies. Moolec Science SA and VivoSim Labs, Inc. are of similar size ($4.3M and $3.9M). Moolec Science SA has the higher net margin (−7.18% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Moolec Science SA leads on 9 and VivoSim Labs, Inc. on 6.

Valuation

Metric MLEC VIVS Biotechnology median
P/E n/m n/m 7.88
P/S 0.00 10.29 11.47
P/B 0.10 n/m 2.52
Price to free cash flow 0.08 n/m 21.16
EV/EBITDA 1.79 0.05 0.74
EV/Sales 0.14 (4.61) 10.73
Earnings yield (1,399.59%) (2,031.82%) (28.84%)
Free cash flow yield 1,260.08% (104.63%) (23.03%)

Profitability

Metric MLEC VIVS Biotechnology median
Gross margin 39.67% 100.00% 65.16%
Operating margin 4.09% (10,116.96%) 0.00%
Net margin (7.18%) (11,016.07%) 0.00%
Free cash flow margin 0.00% (1,014.29%) 0.00%
Return on equity 0.00% (343.10%) (57.72%)
Return on assets 0.00% (155.93%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MLEC VIVS Biotechnology median
Revenue growth (TTM) — (21.13%) 5.64%
EPS growth (last fiscal year) (447.53%) (214.71%) —
Revenue growth, 5-year CAGR — (43.10%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC VIVS Biotechnology median
Debt to equity 4.37 0.00 0.00
Current ratio 0.15 1.70 4.73
Net debt to EBITDA (2.73) 0.45 0.96

Dividend

Metric MLEC VIVS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MLEC VIVS Biotechnology median
Market cap 4.25m 3.92m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack